Methylprednisolone, Indian WHO-GMP supply for inflammatory and autoimmune conditions.
M Care sources methylprednisolone, oral tablets and injectable methylprednisolone sodium succinate alike, from WHO-GMP certified Indian manufacturers for hospital and institutional buyers. We do not manufacture; we coordinate sourcing, documentation and export logistics against your specified strength, pack size and destination requirements.
Methylprednisolone exporter and bulk supplier from India.
M Care sources methylprednisolone in both oral and injectable presentations for institutional buyers who need to cover a formulary rather than a single strength. Tablet supply spans the manufactured range from 2 mg through 32 mg, and injectable methylprednisolone sodium succinate is available as single-dose vials for ward-level dosing or the 1 g multi-dose vial for higher-throughput settings such as infusion units. We coordinate sourcing against the buyer's specified strength and pack format rather than pushing a fixed assortment.
Source
WHO-GMP-certified Indian manufacturing line, named on every quote.
Minimum order
No blanket MOQ. Set by the source manufacturer's minimum batch-release quantity for the strength and pack ordered.
Pricing
On request. Indicative FOB or CIF quote, formal proforma on confirmation.
Incoterms
EXW, FOB, CIF, CIP or DAP.
Payment
Letter of credit (sight or usance) and telegraphic transfer.
Documentation
WHO-GMP certificate of the source line, product-specific CoPP, batch CoA, method of analysis, Free Sale Certificate, Certificate of Origin, CTD or eCTD dossier. On request.
Shelf-life
Minimum remaining shelf-life agreed per order and confirmed on the proforma.
Response
Availability and CoPP status within two working days; pre-alert documents before dispatch.
Oral tablets (2, 4, 8, 16, 24 and 32 mg; 4, 8 and 16 mg are the commonly available strengths) and injectable methylprednisolone sodium succinate in 40 mg and 125 mg single-dose vials and a 1 g multi-dose vial, with WHO-GMP documentation available on request.
Active ingredient
Methylprednisolone (oral); methylprednisolone sodium succinate (injectable). Corticosteroid (glucocorticoid).
Forms and strengths
2 mg; 4 mg; 8 mg; 16 mg; 24 mg; 32 mg; 40 mg (injectable, single-dose vial); 125 mg (injectable, single-dose vial); 1 g (injectable, multi-dose vial).
Indications
Methylprednisolone is a corticosteroid used across inflammatory and autoimmune conditions, available as oral tablets and, as methylprednisolone sodium succinate, as an injectable reconstituted at the point of use. In allergy indications it is used as adjunctive therapy for allergic states such as allergic rhinitis, drug hypersensitivity, transfusion reactions and acute non-infectious laryngeal oedema, alongside primary treatment rather than in place of it.
Storage and handling
Oral tablets (2, 4, 8, 16, 24 and 32 mg; 4, 8 and 16 mg are the commonly available strengths) and injectable methylprednisolone sodium succinate in 40 mg and 125 mg single-dose vials and a 1 g multi-dose vial, with WHO-GMP documentation available on request.
Documentation
Batch-specific CoA, CoPP, manufacturing-site WHO-GMP certificate and stability data compiled per consignment, in the format the destination regulator expects.
Hospital pharmacies, licensed importers and tender desks across our export markets.
India is our origin. We do not sell into the Indian market.
We supply methylprednisolone to hospital pharmacy procurement teams, importers and distributors stocking corticosteroid tablets and injectables, and institutional tender desks across the Gulf, Africa, the UK, the EU, Southeast Asia and Latin America who need documented, WHO-GMP sourced product across both oral and injectable presentations.
GCC registration routes
Supply against MoH registration held by your local licensed importer, or via the GCC central registration pathway.
UK unlicensed routes
Where no UK licence exists, the MHRA Specials and named-patient import routes cover clinically justified demand.
Tender desks
Bid-pack documentation assembled to the tender's specification, from CoPP to batch records.
Dossier support
CTD documentation from the sourcing manufacturer, compiled for your regulator's format.
What the dispensing pharmacist checks on methylprednisolone.
Methylprednisolone is a corticosteroid used across inflammatory and autoimmune conditions, supplied as oral tablets manufactured from 2 mg up to 32 mg, and as methylprednisolone sodium succinate for injection. The injectable is a powder that requires reconstitution at the point of use; it is not dispensed as a ready-to-use solution, and reconstitution and administration follow the receiving facility's own protocols.
In allergy indications, methylprednisolone is used as adjunctive therapy for allergic states, including allergic rhinitis, drug hypersensitivity reactions, transfusion reactions and acute non-infectious laryngeal oedema. It is not a first-line treatment for anaphylaxis: adrenaline remains first-line, with corticosteroids used alongside it rather than as a substitute. Buyers procuring for emergency or allergy-response formularies should stock accordingly and not treat methylprednisolone as a stand-in for adrenaline.
Tablets follow standard oral solid-dose handling. Because both tablet and injectable strengths vary by manufacturer, we confirm which specific strengths and pack sizes (single-dose vs. multi-dose vials) are currently available before an order is finalised.
The documentation pack a regulator actually asks for.
M Care sources methylprednisolone exclusively from Indian manufacturers holding WHO-GMP certification. The standard documentation pack accompanying an order includes the manufacturer's WHO-GMP certificate, a batch-specific certificate of analysis, and any additional regulatory paperwork the destination market's import authority requires. We do not hold manufacturing licences ourselves; our role is to verify and pass through the manufacturer's certification and to arrange the documentation an importer needs at customs.
Because methylprednisolone spans two distinct dosage forms, oral tablets and an injectable requiring reconstitution, documentation requests are handled per form and per strength rather than as a single blanket pack. Buyers should specify the exact tablet strength or vial size (single-dose or multi-dose) needed so the correct manufacturer and paperwork can be matched to the order.
CoA and MoA, per batch
Batch-specific certificate and method of analysis from the sourcing manufacturer's QC release.
CoPP, WHO-GMP, MFG licence
Certificate of pharmaceutical product and site GMP certification issued via CDSCO channels, naming the actual manufacturing site.
CTD Module 3
Chemistry, manufacturing and controls documentation available from the sourcing manufacturer for registration filings.
Pack insert, labels, artwork
Destination-language patient information and labelling to the local regulator's standard, locked before shipment.
Pharmacovigilance
A named PV contact arranged in the destination market where the registration requires one.
Adjacent lines procurement desks order alongside methylprednisolone.
Tacrolimus
Another immunomodulatory agent sourced for hospital and specialist buyers.
Musculoskeletal & Pain category hub
Browse the full musculoskeletal and pain-management category.
Allergy & Immunology category hub
Methylprednisolone's adjunctive allergy indications sit within this category.
Anaesthesia & ICU category hub
Relevant for buyers stocking injectable corticosteroids alongside ICU and emergency agents.
Molecule · strength · volume · destination. One working day to a quote.
- Send us the specifics. Form and strength, pack preference, destination market and indicative volume for methylprednisolone.
- We route to the right line. The enquiry goes to the WHO-GMP certified manufacturing partner whose certificates fit your regulator.
- Commercial and regulatory offer. FOB or CIF price with the documentation list, named manufacturing site and current certificate validity.
- Order, produce, release, ship. QC release on the Indian side, batch documents compiled, despatch on the agreed incoterm.
- After delivery. Batch records and certificates archived and retrievable for the life of the product on your shelf.
Methylprednisolone supply, the specific questions.
What forms of methylprednisolone does M Care supply?
Both oral tablets, across the manufactured range of 2, 4, 8, 16, 24 and 32 mg, and injectable methylprednisolone sodium succinate as 40 mg and 125 mg single-dose vials and a 1 g multi-dose vial. Not every strength is held by every manufacturer we work with; we confirm current availability against your specification before quoting.
Is methylprednisolone manufactured in a WHO-GMP facility?
Yes. We source methylprednisolone from Indian manufacturers holding WHO-GMP certification and supply the underlying certificates, batch-specific certificates of analysis and other regulatory documents alongside the shipment.
Is the injectable form ready to use or does it require preparation?
Methylprednisolone sodium succinate is supplied as a powder for reconstitution. It is not a ready-to-use solution; it requires reconstitution before administration by the receiving facility's own pharmacy or clinical staff, per the product's own labelling.
Can methylprednisolone be used as a first-line treatment for anaphylaxis?
No. Adrenaline remains the first-line treatment for anaphylaxis. Methylprednisolone is used as adjunctive therapy in allergic states, including allergic rhinitis, drug hypersensitivity reactions, transfusion reactions and acute non-infectious laryngeal oedema, alongside the primary treatment, not in its place.
Which strengths are most commonly held in stock by manufacturers?
4 mg, 8 mg and 16 mg tablets are the most commonly available oral strengths across our manufacturer network. The 2, 24 and 32 mg tablet strengths and both injectable vial sizes are sourced on a case-by-case basis depending on which manufacturers currently hold them.
What documentation is provided with a methylprednisolone order?
Standard documentation includes the manufacturer's WHO-GMP certificate, product-specific certificate of analysis, and other regulatory paperwork required for import, tailored to the destination market's requirements.
Send the specifics. You'll have a price inside one working day.
Form and strength, destination market and indicative volume. The Mumbai desk replies within one working day, including when the honest answer is that the route is not viable yet.